Moderna, Merck report positive results from cancer-vaccine study

Moderna and Merck’s cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b ...
WTVD

Moderna COVID vaccine performs as well in children as it does in adults, company says

CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...
FOX 10 Phoenix

Study shows Moderna’s COVID-19 vaccine could lead to more side effects than Pfizer/BioNTech’s

New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get ...
Reuters

Moderna on track to report late-stage COVID-19 vaccine data next month

Oct 29 (Reuters) - Moderna Inc (MRNA.O), opens new tab on Thursday said it is on track to report early data from a late-stage trial of its experimental COVID-19 vaccine next month, offering the ...